author-photo

Arvind Arumainathan

Clatterbridge Cancer Centre NHS Foundation Trust

17

Papers

84

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Case Report: A rare case of a vanishing unilateral effusion

2020 F1000Research
Show All
- Source
- Cite
- Save
Citations (0)
An unexpectedcause of iron deficiency.

2020 Gut
Show All
- Source
- Cite
- Save
Citations (0)
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (15)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (27)
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (10)
Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis

2018 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

2018 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (6)
POST-AUTHORISATION OBSERVATIONAL SAFETY STUDY OF BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA AND SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA: ARROVEN STUDY

2015
Show All
- Source
- Cite
- Save
Citations (0)